Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients

Molecular Biology Reports

Volumn 40, Issue 8, 2013, Pages 4889-4892

  Duarte, Angela Luzia Branco Pinto ^a   Dantas, Andréa Tavares ^a,b   De Ataíde Mariz, Henrique ^a,b   Dos Santos, Flaviana Alves ^b   Da Silva, Juliana Cruz ^b   Da Rocha Jr , Laurindo Ferreira ^a,b   Galdino, Suely Lins ^b   Galdino Da Rocha Pitta, Maira ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Laboratório de Imunomodulação e Novas Abordagens Terapêuticas Núcleo de Pesquisa Em Inovação Terapêutica Suely Galdino   (Brazil)

Author keywords

Cytokines; Interleukin 27; Nephritis; SLEDAI; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT CH50; CORTICOSTEROID; DOUBLE STRANDED DNA; INTERLEUKIN 27; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THALIDOMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAZILIAN; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; HEMATURIA; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PROTEIN BLOOD LEVEL; PROTEINURIA; RATING SCALE; SLEDAI; SLICC SCORE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84881163452     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2588-1     Document Type: Article

References (22)

1. Yap DY, Lai KN (2010) Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol 2010:365083
2. Amel-Kashipaz MR, Huggins ML, Lanyon P, et al. (2001) Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus. J Autoimmun 17(2):155-163
3. Chen DY, Chen YM, Wen MC, et al. (2012) The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus. 2012 Aug 14. [Epub ahead of print]
4. Zhao XF, Pan HF, Yuan H, et al. (2010) Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 37:81-85
5. Pflanz S, Timans JC, Cheung J, et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16(6):779-790
6. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA (2006) IL-27 limits IL-2 production during Th1 differentiation. J Immunol 176(1):237-247
7. Liu H, Rohowsky-Kochan C (2011) Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J Interferon Cytokine Res 31(5):459-469
8. Awasthi A, Carrier Y, Peron JP, et al. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380-1389
9. Shen H, Xia L, Xiao W, Lu J (2011) Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arthritis Rheum 63(3):860-861
10. Yoshizaki A, Yanaba K, Iwata Y, et al. (2011) Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis 70(1):194-200
11. Shibata S, Tada Y, Kanda N, et al. (2010) Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130(4):1034-1039
12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
13. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288-291
14. Sugiyama N, Nakashima H, Yoshimura T, et al. (2008) Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis 67(10):1461-1467
15. Li TT, Zhang T, Chen GM, et al. (2010) Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med 58(5):737-739
16. Shimizu S, Sugiyama N, Masutani K, et al. (2005) Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J Immunol 175(11):7185-7192
17. Igawa T, Nakashima H, Sadanaga A, et al. (2009) Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod Rheumatol 19(1):33-41
18. Kwan BC, Tam LS, Lai KB, et al. (2009) The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48(12):1491-1497
19. Wong CK, Ho CY, Li EK, et al. (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589-593
20. + T cells partially through STAT3-dependent mechanism. J Immunol 177:5377-5385
21. Diveu C, McGeachy MJ, Boniface K, et al. (2009) IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol 182:5748-5756
22. + T cells. J Immunol 183(4):2435-2443